Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …

Lung cancer is one of the leading causes of death worldwide. There are 2 major subtypes of
lung cancer, non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) …

Over the past decade, lung cancer treatment has undergone a major paradigm shift. A
greater understanding of lung cancer biology has led to the development of many effective …

Emerging evidence on the role of the antitumor activity of the immune system has generated
great interest in immunotherapy even for tumors that were historically considered as …

Lung cancer is the leading cause of cancer-related death worldwide. Treatment of non-small
cell lung cancer has evolved tremendously over the past decade. Specifically, immune …

Many decades in the making, immunotherapy has demonstrated its ability to produce
durable responses in several cancer types. In the last decade, immunotherapy has shown …

Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Background: The treatment of non-small-cell lung carcinoma (NSCLC) has changed
markedly in recent years as a result of two major treatment milestones: Targeted therapy and …

Over the last several years, new therapeutic targets have emerged in immunotherapy,
particularly the immune checkpoint pathways. Blocking inhibitory pathways via monoclonal …

Lung carcinoma is the leading cause of death by cancer worldwide. When possible, surgery
is the best treatment strategy for patients with non–small-cell lung cancer. However, even …